IP Library › Patent Application 17322061
Patent Application
App. No. 17/322,061

Guiding Musculoskeletal Procedures

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
17/322,061
Abstract

A method may include providing a syringe device having (a) a single needle, (b) a first syringe comprising saline with microbubbles, (c) a second syringe comprising a therapeutic compound, and (d) a connector coupling the single needle to the first syringe and to the second syringe. The method may further include guiding the single needle to an injection site of a patient; injecting, with the first syringe, a quantity of saline with microbubbles; confirming a desired position of the single needle, with ultrasound imaging, by identifying the microbubbles in the quantity of saline relative to a tip of the single needle and further relative to one or more anatomical landmarks visible with the ultrasound imaging; and injecting, with the second syringe, the therapeutic compound at the injection site.

Claims (23)

1 . A method comprising:

providing a syringe device having a single needle, a first syringe comprising saline with microbubbles, a second syringe comprising a therapeutic compound, and a connector coupling the single needle to the first syringe and to the second syringe;

guiding the single needle to an injection site of a patient;

injecting, with the first syringe, a quantity of saline with microbubbles;

confirming a desired position of the single needle, with ultrasound imaging, by identifying the microbubbles in the quantity of saline relative to a tip of the single needle and further relative to one or more anatomical landmarks visible with the ultrasound imaging; and

injecting, with the second syringe, the therapeutic compound at the injection site.

2 . The method of claim 1 , wherein the therapeutic compound comprises a corticosteroid.

3 . The method of claim 1 , wherein the therapeutic compound comprises lidocaine.

4 . A method comprising:

providing a syringe device having a single needle, a first syringe comprising saline with microbubbles, a second syringe configured to aspirate fluid from a treatment site of a patient, and a connector coupling the single needle to the first syringe and to the second syringe;

guiding the single needle to the treatment site;

injecting, with the first syringe, a quantity of saline with microbubbles;

confirming a desired position of the single needle, with ultrasound imaging, by identifying the microbubbles in the quantity of saline relative to a tip of the single needle and further relative to one or more anatomical landmarks visible with the ultrasound imaging; and

aspirating, with the second syringe, fluid from the treatment site.

5 . A method comprising:

providing a syringe device having a single needle, a first syringe comprising saline with microbubbles and having a first-syringe plunger, a second syringe having a second-syringe plunger that is independently operable relative to the first-syringe plunger, and a connector coupling the single needle to the first syringe and to the second syringe;

guiding the single needle to a treatment site of a patient;

injecting, with the first syringe, a quantity of saline with microbubbles;

confirming a desired position of the single needle, with ultrasound imaging, by identifying the microbubbles in the quantity of saline relative to a tip of the single needle and further relative to one or more anatomical landmarks visible with the ultrasound imaging; and

with the second syringe, injecting a therapeutic compound at the treatment site or aspirating fluid from the treatment site.

6 . The method of claim 5 , wherein injecting with the first syringe comprises depressing the first-syringe plunger.

7 . The method of claim 5 , wherein the second syringe comprises the therapeutic compound, and wherein injecting the therapeutic compound comprises depressing the second-syringe plunger.

8 . The method of claim 5 , wherein the second syringe is configured to aspirate fluid from a treatment site of a patient, and wherein aspirating fluid from the treatment site comprises drawing back the second-syringe plunger.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 24, 2022
From: CLYBURN, MORGAN; TRAUNER, KENNETH, DR
To: AGITATED SOLUTIONS INC.
Reel/Frame 059093/0315 →